Transforming growth factor β1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma

Growth Factors

Volumn 16, Issue 2, 1998, Pages 101-110

  Royuela, Mar ^a   De Miguel, María P ^a   Bethencourt, Fermín R ^b   Sanchez Chapado, Manuel ^b   Fraile, Benito ^a   Paniagua, Ricardo ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Human prostate; Prostate adenocarcinoma; Transforming growth factor 1 (TGF 1); Transforming growth factor 1 receptor types I (TGF RI) and II (TGF RII)

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BASAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SIGNAL TRANSDUCTION; STROMA CELL;

EID: 0032439774     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977199809002121     Document Type: Article

References (50)

1. Anzano, M.A., Roberts, A.B., Smith, J.M., Sporn, M.B. and De Larco, J.E. (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and type β transforming growth factors. Proc. Natl. Acad. Sci. USA 80, 6264-6268.
2. Barrack, E.R. (1997) TGFβ in prostate cancer: A growth inhibitor that can enhance tumorigenicity. Prostate 31, 61-70.
3. Bascom, C.C., Wolfshohl, J.R., Coffey, R.J., Madisen, L., Webb, N.R., Purchio, A.R., Derynck, R. and Moses, H.L. (1989) Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol. Cell. Biol. 9, 5508-5515.
4. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72, 248-254.
5. Contractor, H.E., Breul, J. and Barrack, E.R. (1994) Potential role of T-lymphocytes in prostate tumour growth enhancement by transforming growth factor beta 1 (TGFβ1). J. Urol. 151, 336A.
6. Cunha, G.R. (1994) Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74, 1030-1044.
7. Cheifetz, S., Hernandez, H., Laiho, M., Ten Dijke, P., Iwata, K.K. and Massagué, J. (1990) Distinct transforming growth factor-β receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J. Biol. Chem. 265, 20553-20538.
8. Danielpour, D., Dart, L.L., Flanders, K.C., Roberts, A.B. and Sporn, M.B. (1989) Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol. 138, 79-86.
9. Delarco, J.E. and Todaro, G.J. (1978) Growth factors from murine sarcoma virus transformed cells. Proc. Nail. Acad. Sci. USA 75, 4001-4005.
10. Derynck, R., Goeddel, D.V., Ullrich, A., Guttermamn, J.U., Williams, R.D., Bringman, T.S. and Berger, W.H. (1987) Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res. 47, 707-712.
11. Desgrandchamps, F., Cussenot, O., Teillac, P., Calvo, F. and Le Duc, A. (1992) A growth factor expression in epithelial or fibroblastic cells culture derived from normal or benign prostatic hyperplasia. Urol. Res. 20, 6.
12. Djonov, V., Ball, R.K., Graf, S., Mottaz, A.E., Arnold, A.M., Flanders, K., Studer, U.E. and Merz, V.W. (1997) Transforming growth factor-β3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma. Prostate 31, 103-109.
13. Eastham, J.A., Truong, L.D., Rogers, E., Kattan, M., Flanders, K.L., Scardino, P.T. and Thompson, T.C. (1995) Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab. Invest. 73, 628-635.
14. Filmus, J., Zhao, J. and Buick, R.N. (1992) Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor β-1 (TGF-β1) and alters the number and type of TGF-β1 receptors in rat intestinal epithelial cell clones. Oncogene 7, 521-529.
15. Guo, Y., Jacobs, S. and Kyprianou, N. (1997) Down-regulation of protein and mRNA expression for transforming growth factor-β1 (TGF-β1) type I and type II receptors in human prostate cancer. Int. J. Cancer 71, 573-579.
16. Habib, F.K. (1994) The role of growth factors in the pathogenesis of BPH. In: Progress in Clinical and Biological Research, Vol. 386. Wiley-Liss, Inc., New York, pp. 43-50.
17. Kaighn, M.E., Reddel, R.R. and Lechner, J.F. (1989) Transforming of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res. 49, 3050-3056.
18. Kim, I.Y., Ahn, H.J., Zelner, D.J., Shaw, J.W., Sensibar, J.A., Kim, J.H. and Kato, M. (1996a) Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res. 56, 44-48.
19. Kim, I.Y., Kim, J.H., Zelner, D.J., Ahn, H.J., Sensibar, J.A. and Lee, C. (1996b) Transforming growth factor-β1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP. Endocrinology 137, 991-999.
20. Kyprianou, N. and Isaacs, J.T. (1988) Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 123, 2124-2131.
21. Kyprianou, N. and Isaacs, J.T. (1989) Expression of transforming growth factor-β in rat ventral prostate during castration-induced programmed cell death. Mol. Endocrinol. 3, 1515-1522
22. Lin, H.Y., Wang, X.F., Ng-Eaton, E., Weinberg, R.A. and Lodish, H.F. (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.
23. Lindström, P., Bergh, A., Holm, I. and Damber, J. (1996) Expression of transforming growth factor-β1 in rat ventral prostate and dunning R3327PAP prostate tumor after castration and estrogen treatment. Prostate 29, 209-218.
24. Massagué, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell. Biol. 6, 597-641.
25. Massagué, J. (1992) Receptors for the TGF-β family. Cell 69, 1067-1070.
26. McKeehan, W.I. and Adams, P.S. (1988) Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In vitro Cell. Dev. Biol. 24, 243-246.
27. + myc-induced carcinomas in reconstituted mouse prostate: Evidence for a paracrine role during progression. Mol. Endocrinol. 5, 503-513.
28. Miller, D.A., Pelton, R.W., Derynck, R. and Moses, H.L. (1990) Transforming growth factor beta. Ann. N. Y. Acad. Sci. USA 593, 208-217.
29. Mitchen, J.L., Rago, R. and Wilding, G. (1990) Effects of suramin and TGFβ on the proliferation of primary epithelial cultures from normal, benign hyperplastic and cancerous human prostates. Am. Association Cancer Res. 31, 1289-1294.
30. Mori, H., Maki, M. and Oishi, K. (1990) Increased expression of genes for basic fibroblast growth factor and transforming growth factor type 2 in human benign prostatic hyperplasia. Prostate 16, 71-80.
31. Morton, D.M. and Barrack, E.R. (1995) Modulation of transforming growth factor-β1 effects in prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res. 55, 2596-2602.
32. Moses, H.L., Yang, E.Y. and Pietenpol, J.A. (1990) TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247.
33. Mulder, K.M., Segarini, P.R., Morris, S.L., Ziman, J.M. and Choi, H.G. (1993) Role of receptor complexes in resistance or sensitivity to growth inhibition by TGFβ in intestinal epithelial cell clones. J. Cell Physiol. 154, 162-169.
34. Ruscetti, F., Varesio, L., Ochoa, A. and Ortaldo, J. (1993) Pleiotropic effects of transforming growth factor-β on cells of the immune system. Ann. N. Y. Acad. Sci. 685, 488-500.
35. Sporn, M.B. and Roberts, A.B. (1988) Transforming growth factor-beta: new chemical forms and new biological roles. Biofactors 1, 89-93.
36. Steiner, M.S. and Barrack, E.R. (1992) Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol. 6, 15-25.
37. Steiner, M.S., Zhou, Z., Tonb, D.C. and Barrack, E.R. (1994) Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 135, 2240-2247.
38. Story, M.T., Baeten, L.A., Molter, M.A. and Lawson, R.K. (1990) Influence of androgen and transforming growth factor beta on basic fibroblast growth factor levels in human prostate derived fibroblast cell cultures. J. Urol. 143, 241A.
39. Story, M.T. (1991) Polypeptide modulators of prostatic growth and development. Cancer Surveys 11, 123-146.
40. Story, M.T., Hopp, K.A. and Meier, D.A. (1996) Expression of transforming growth factor betal (TGFβ1), -β2, and -β3 by cultured human prostate cells. J. Cell. Physiol. 169, 97-107.
41. Ten Dijke, P., Hansen, P., Iwata, K.K., Pieler, C. and Foulkes, J.G. (1988) Identification of a new member of the transforming growth factor type β gene family. Proc. Natl. Acad. Sci. USA 85, 4715-4719.
42. Thompson, T.C., Truong, L.D., Timme, T.L., Kadmon, D., McCune, B.K., Flanders, K.C., Scardino, P.T. and Park, S.H. (1992) Transforming growth factor β1 as a biomarker for prostate cancer. J. Cell. Biochem. 16H, 54-61.
43. Torre-Amione, G., Beauchamp, R.D., Koeppen, H., Park, B.H., Schreiber, H., Moses, H.L. and Rowley, D.A. (1990). A highly immunogenic tumor transfected with a murine transforming growth factor type β-1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA 87, 1486-1490.
44. Tu, H., Jacobs, S.C., Borkowski, A. and Kyprianou, N. (1996) Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-β1 and bcl-2 expression. Int. J. Cancer 69, 357-363.
45. Truong, L., Kadmon, D., McCune, B., Flanders, K., Scardino, P. and Thompson, T. (1993) Association of transforming growth factor-β1 with prostate cancer: an immunohistochemical study. Hum. Pathol. 24, 4-9.
46. Ueki, N., Nakazato, M., Ohkawa, T., Ikeba, T., Amuro, Y., Hada, T. and Higashino, K. (1992) Excessive production of transforming growth-factor β1 can play an important role in the development of tumorigenesis. Biochim. Biophys. Acta 1137, 189-196.
47. Wikström, P., Bergh, A. and Damber, J.E. (1997) Expression of transforming growth factor-β receptor type I and type II in rat ventral prostate and dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment. Urol. Res. 25, 103-111.
48. Wilding, G. (1991) Response of prostate cancer cells to peptide growth factors: Transforming growth factor-β. Cancer Surveys 11, 147-163.
49. Wilding, G., Zugneier, G., Knable, C., Flanders, K. and Gelmann, E. (1989) Differential effects of TGF-β on human prostate cancer cells in vitro. Mol. Cel. Endocrinol. 62, 79-87.
50. Wrana, J.L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. and Massagué, J. (1992) TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.